In the first three quarters of 2022, Allscripts generated revenue of $446 million, up roughly 6% from the same period in 2021. Veradigm was the main driver of the growth, making up more than 95% of the company’s overall sales.“As our markets continue to evolve, completing our brand transition to Veradigm represents a capstone on our own evolution as a company,” Veradigm CEO Rick Poulton said in a statement. Poulton has been CEO since May 2022, when previous …
According to a release, allscripts is changing its corporate name to Veradigm, to reflect the health IT company’s focus on growth across each of its market segments, including payers, life sciences and providers. Allscripts worked on transitioning its products to the Veradigm brand in 2022 as it streamlined its corporate portfolio following a difficult few years. All remaining Allscripts assets, including EHRs, practice management systems, and patient communication platforms are now integrated into Veradigm’s network, which …
